Wound Care Market Prepared to Take a Beating
Wound care has come a long way since the days of biting the bullet and gauze bandages. Recent advancements in the treatment of wounds and […]
Wound care has come a long way since the days of biting the bullet and gauze bandages. Recent advancements in the treatment of wounds and […]
Cancer drug sales are slowing down in the U.S., Reuters reported Monday.
Advanced Life Sciences (OTC BB: ADLS) took two steps this week toward advancing its lead drug candidate, Restanza.
Wired magazine recently published a feature on Cytori Therapeutics, a regenerative medicine company based in San Diego that is using stem and regenerative stem cells derived from fat (adipose) tissue to repair breasts disfigured by mastectomies and lumpectomies.
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
Could the same hormone that regulates your appetite keep you from developing Alzheimer’s?
Cardiogenesis, the clinical and market leader in transmyocardial revascularization (TMR), revealed this week that it has enrolled its first two patients for its feasibility study involving the cutting-edge PHOENIX System.
Time is critical when a patient suffers from a stroke.
Medical device company NeoVista, Inc., recently announced 12-month results from its MERITAGE study in patients with wet age-related macular degeneration, a leading cause of vision loss in older Americans.
This company is a biopharmaceutical company that has developed a targeted drug platform that specifically modulates the bioactive enzyme protein kinase C in the treatment of various conditions, including heart disease and acute chronic pain. Protein kinase C is a fundamental bioactive protein that plays a critical role in cellular signaling pathway’s, and through…
Copyright © 2025 | WordPress Theme by MH Themes